Staar Surgical (STAA) Shares Outstanding (Diluted Average) (2010 - 2026)
Staar Surgical (STAA) reported Shares Outstanding (Diluted Average) of $50.9 million for Q2 2026, up 3.15% on a YoY basis from $49.3 million in Q2 2025, and up 2.69% quarter-over-quarter from $49.6 million in Q1 2026.
Staar Surgical (STAA) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Staar Surgical has reported Shares Outstanding (Diluted Average) for 12 years, with the latest figure at $50.9 million in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Diluted Average) rose 3.15% year-over-year to $50.9 million; the trailing twelve-month figure through Apr 2026 stood at $50.9 million (up 3.15% YoY), and the FY2026 full-year result was $49.6 million, up 0.9% from the prior year.
- Shares Outstanding (Diluted Average) for Q2 2026 stood at $50.9 million, up from $49.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $50.9 million in Q2 2026, with the low at $48.9 million in Q1 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $49.5 million across 5 years, with a median of $49.4 million in 2023.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) declined 1.2% — and 2026, when it climbed 3.15%.
- Staar Surgical's Shares Outstanding (Diluted Average) stood at $49.4 million in 2022, then increased by 0.1% to $49.4 million in 2023, then declined by 0.61% to $49.1 million in 2024, then gained by 2.9% to $50.5 million in 2025, then increased by 0.69% to $50.9 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $50.9 million (Q2 2026), $49.6 million (Q1 2026), and $50.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Staar Surgical | 1.44 Bn | 1.27 Bn | 68.86 Mn | 50.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 50.90 Mn |
| Jan 2, 2026 | 49.57 Mn |
| Sep 26, 2025 | 50.55 Mn |
| Jun 27, 2025 | 49.52 Mn |
| Mar 28, 2025 | 49.34 Mn |
| Dec 27, 2024 | 49.13 Mn |
| Sep 27, 2024 | 49.61 Mn |
| Jun 28, 2024 | 49.53 Mn |
| Mar 29, 2024 | 48.91 Mn |
| Dec 29, 2023 | 49.43 Mn |
| Sep 29, 2023 | 49.37 Mn |
| Jun 30, 2023 | 49.52 Mn |
| Mar 31, 2023 | 49.50 Mn |
| Dec 30, 2022 | 49.38 Mn |
| Sep 30, 2022 | 49.37 Mn |
| Jul 1, 2022 | 49.22 Mn |
| Apr 1, 2022 | 49.29 Mn |
| Dec 31, 2021 | 49.46 Mn |
| Apr 3, 2015 | 38.48 Mn |
| Oct 3, 2014 | 38.37 Mn |